Article Versions Notes

Jehl A, Conrad O, Burgy M, Foppolo S, Vauchelles R, Ronzani C, Etienne-Selloum N, Chenard M-P, Danic A, Dourlhes T, et al. Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction. Cells. 2023; 12(5):733. https://doi.org/10.3390/cells12050733

Jehl, Aude, Ombline Conrad, Mickaël Burgy, Sophie Foppolo, Romain Vauchelles, Carole Ronzani, Nelly Etienne-Selloum, Marie-Pierre Chenard, Aurélien Danic, Thomas Dourlhes, and et al. 2023. "Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction" Cells 12, no. 5: 733. https://doi.org/10.3390/cells12050733

Jehl, A., Conrad, O., Burgy, M., Foppolo, S., Vauchelles, R., Ronzani, C., Etienne-Selloum, N., Chenard, M.-P., Danic, A., Dourlhes, T., Thibault, C., Schultz, P., Dontenwill, M., & Martin, S. (2023). Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction. Cells, 12(5), 733. https://doi.org/10.3390/cells12050733